CLINICAL_TRIALS
trial_result
· 2009-11-19
Clinical Trial Update: Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (PTSD) [Phase 2]
Summary
Phase 2 clinical trial evaluating BRL29060A (paroxetine hydrochloride hydrate) for PTSD was terminated with results posted in 2009.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Post-Traumatic Stress Disorder, Stress Disorders, Post-Traumatic | Phase 2 | Status: TERMINATED | Results posted: 2009-11-19